Rybelsus contains semaglutide, a once-daily oral GLP-1 receptor agonist designed to improve blood sugar control in type 2 diabetes and support weight loss. Available in 3mg, 7mg, and 14mg tablets, Rybelsus helps reduce appetite, lower HbA1c levels, and promote healthier eating habits. It offers an effective alternative to injectable semaglutide treatments like Ozempic, making it […]
